Calendar of Events

Registration is required.

Today, toxicological evaluation of chemicals is beginning to take advantage of the on-going revolution in biology and biotechnology. This revolution is making it increasingly possible to study the effects of chemicals using cells, cellular components, and tissues—preferably of human origin—rather than whole animals. In carrying out its mission to protect and promote public health, FDA must use the best scientific and technological information available to make decisions on the products it regulates. Regulators must assure their toxicology toolbox keeps pace with advances in science and technology. This workshop will discuss at how one important toxicology tool, the rodent chronic bioassay, should be redesigned to meet the needs of 21st century risk assessment.

• Onsite Registration deadline is February 12, 2019
• Onsite seating has no cost, however, attendees must pass through security (please see Meeting Website for details).
• Preregistration is required for any Non-Federal employee.
• US Federal employees may register on-site.
• Webcast Registration is also available for this session (please see Meeting Website to register for the webcast).
• Please Note: This is not a public forum for discussion of toxicology regulatory issues.

• Harvey W. Wiley Federal Building-(Harvey Auditorium), 5001 Campus Dr., College Park Maryland 20740
• Parking is limited and must be reserved in advance by indicating the parking request on the registration form.

Quality mentoring experiences enhance trainee’s overall research experiences whether they are in the undergraduate, graduate, or postdoctoral phase of their careers. Mentoring is a critical professional development activity as trainees are able to engage in professional socialization as well as build a wealth of knowledge pertinent to their field. However, identifying mentor candidates and successfully managing those relationships once established is often a challenge for which many trainees are not prepared. This webinar will help attendees build a toolbox equipped with methods on how to successfully identify quality mentors in different environments (e.g., trainees’ home institutions, scientific societies, etc.) and how to maintain those critical relationships over time. Our panel will provide insight on how to be a proactive mentee and navigate the challenges associated with developing successful, enduring mentor-mentee relationships. A 30 minute Q&A discussion with attendees will follow panelist presentations.

Registration is required.

The Scientific Sessions are designed by experts and researchers from allaround the world who will be showcasing their research and expertise in thefield of Breast Cancer and Women Health.

The successful 8th World Congress on Breast CancerManagement & Therapy created an awesome impact by networking experts fromEast Asia to UK. 50000visitors visited and submitted their work and broke down to meet and explore theprestigious event Breast Cancer 2018 at London, UK.

We welcome you to start off your journey with us at 9th European Congress on Breast Cancer, Women's Health& Therapeutics in the City of Lights-Paris, France

Showcase your recent research
Keynote sessions by emeritus of renowned Universities and Industries
Strengthen your research opportunities with the experts.
Collaborations with the Med Kings of the field
Opportunity to meet highly eminent Speakers and Sponsorship.
Poster, e-poster, exhibiting and speaker sessions which can be accessed evenafter the conference.

The Scientific Sessions are designed by experts and researchers from all around the world who will be showcasing their research and expertise in the field of Breast Cancer and Women Health.

The successful 8th World Congress on Breast Cancer Management & Therapy created an awesome impact by networking experts from East Asia to UK. 50000 visitors visited and submitted their work and broke down to meet and explore the prestigious event Breast Cancer 2018 at London, UK.

We welcome you to start off your journey with us at 9th European Congress on Breast Cancer, Women's Health& Therapeutics in the City of Lights-Paris, France

Showcase your recent research
Keynote sessions by emeritus of renowned Universities and Industries
Strengthen your research opportunities with the experts.
Collaborations with the Med Kings of the field
Opportunity to meet highly eminent Speakers and Sponsorship.
Poster, e-poster, exhibiting and speaker sessions which can be accessed even after the conference.

This DDTSS webinar is focused on “In Vitro Platforms to Detect CNS Toxicity.” CNS toxicity is one of the main causes of pre-clinical and clinical drug attrition. And there currently is a lack of early in vitro tools for de-risking CNS toxicity liability during discovery stage. In this webinar, panelists Mohamed Krier, PhD (Janssen Pharmaceutical Company) and Qin Wang, PhD (Takeda Pharmaceuticals, Inc) will discuss two new assays being developed to predict seizure and/or neurodegeneration. Dr Krier will present on the multielectrode array (MEA) platform to detect seizure with rat cortical and hiPSC-neurons and Dr. Wang will present on the utility of hiPSC-derived 3D microbrain to detect seizure and neurodegeneration. This webinar will benefit a broad range of people from graduate students and postdocs to early career toxicologists interested in broadening their knowledge on current in vitro platforms being developed to detect neurotoxicity.

Registration is required.

Join us in Valencia, Spain from 7-9 March 2019 to be a part of this growing interdisciplinary and international community.

Abstract Submission Deadline: 9 October 2018
Early Bird Registration Deadline: 18 December 2018

Quality content. The agenda is packed with carefully selected talks on topics as diverse as the challenges you face.

Tailor your experience. 4 parallel streams give you the chance to personalise your agenda and delve deep into the topics pertinent to your challenges. Choose from Small Molecules, Biologics, Technology And Innovation or Device Development.

Key themes for 2019 include:

Ensure credibility:
Bring new levels of data quality with replicable study standards, transparency, technological assurance and analytical excellence

Unite and grow capabilities:
Accelerate the growth of the data ecosystem through collaboration with more stakeholders, breaking silos and maximising combined expertise

• David Leather, VP, Medical Respiratory Franchise, Salford Lung Study Lead, GSK
• Khair ElZarrad, Deputy Director, Office of Medical Policy, FDA
• Christoph von der Goltz, Senior Director, Head of HEOR and RWE, Lundbeck
• Giuseppe Rosano, Member CVWP, European Medicines Agency, Consultant Cardiologist, Agenzia Italiana del Farmaco
• Andrew Bate, Senior Director, Analytics Team Lead, Epidemiology, Pfizer
• Amanda Golembesky, Executive Director, Epidemiology, Boehringer Ingelheim

As the global threat of antimicrobial resistance continues to grow, the advances of modern medicines are at risk of being lost. Failure to act quickly means the spread of antibiotic-resistant bacteria could lead to increased mortality from normally minor injuries and benign infections.

SMi’s highly anticipated Superbugs & Superdrugs conference is set to return to London, UK for its 21st year running, on the 18th & 19th March 2019. This year’s event aims to provide valuable insights and key updates on the latest developments within the scientific communities, as well as the processes and strategies pharmaceuticals use to develop novel therapeutics that utilise alternative mechanisms to treat multi-drug resistant infections.

The two-day conference will also host a diverse gathering of policy makers and economists, in addition to big pharmas and biotechs, who will discuss incentives, partnerships, regulations and new policies. Industry experts and scientific pioneers are set to present on their research advances and clinical data, as well as alternatives to antibiotics, such as monoclonal antibodies and antimicrobial peptides.

2019 HIGHLIGHTS:

• Analyse the current status of antimicrobial resistance with industry-led insight into current strategies to tackle AMR
• Hear about novel immune-therapeutics to target Gram-negative bacterial infections
• Learn about strategies to combat ß-lactamases
• Evaluate the development of precision antibiotics: Agents designed to meet the demands of stewardship
• Explore the role of plasmids in the evolution of antimicrobial resistance

Join us in London next year to explore the challenges and solutions to the growing threat of antibiotic resistance, as well as take part in interactive roundtable discussions with leading organisations. Attendees will also have the exclusive opportunity of networking with an unrivalled gathering of senior experts from Wellcome Trust, F2G, Summit Therapeutics, Meiji Seika Pharma, Akthelia Pharmaceuticals, Centauri Therapeutics, and many more.

For more information and to register online, please visit http://www.superbugssuperdrugs.com/toxicologywl

For more information, please contact Maria Mandic on:
E: mmandic@smi-online.co.uk
T: +44 (0) 20 7827 6124

It will help you to optimize your manufacturing and process development strategies to further reduce the cost of off-the-shelf NK cell therapies. Discuss the most up to date clinical data on genetically engineered NK cells from CARs to bispecific engagers and ensure persistence and durability.

Toxicology-2019 conference includes, Keynote Addresses and Plenary Talks by eminent personalities from around the world in addition to contributed papers both oral and poster presentations. The conference is a gathering of experts, professionals, academicians and researchers from all over the world dedicated to a safer global community.

• Registration Deadline: March 20, 2019

Top Five Reasons to Attend
1. Focus on stronger teamwork between formulation and medicinal chemistry
2. New insights on continuous manufacturing during early development
3. Improved drug delivery options for immuno-oncology and regenerative medicines
4. Innovative CNS delivery methods across the blood-brain barrier
5. Strategies to select the least painful drug delivery methods

ILSI Nort America is pleased to announce the 2019 conference:

Scientific Advances and Challenges in Safety Evaluation of Food Packaging Materials: Exposure Considerations in a Hazardous World. April 2-3, 2019 at the The Westin Washington, DC City Center

This global two-day conference will provide a forum to discuss state of the science on analytics, exposure, toxicology and risk assessment as they relate to food packaging safety. Public and private scientists, consultants, non-profits and students are encouraged to attend and submit poster abstracts. Abstracts must be submitted online by March. Schedule, speaker bios, and registration instructions are available at: http://ilsina.org/event/2019-food-packaging-conference/

Free registration for academics, government and non-profits. Early bird registration deadline is March 15

This one of its kind scientific platform with elite professionals from the field of paediatric neurology, will give you the opportunity to network, build relations, and exchange knowledge.

So come and join the Join the Dubai International Paediatric Neurology Congress and be a part of this exceptional congress for a remarkable learning and networking experience.
Price: USD 199-2199

Start Time: 8:00 AM End Time: 5:00 PM

We would like to welcome you as distinguished guests to attend the World Heart Congress which will be held in Toronto, Canada during April 08-09, 2019.

World Heart Congress is designed to bring forth the most up to date information on cardiology, with a timely Theme "Stimulating Eminence in Cardiology and Healthcare". The World Heart Congress meeting will be accompanied with many professional attributes of great quality, and the selected venue will allow conference speakers and attendees opportunities to engage in collaborative efforts while learning more about some of the current trends and research practices applied to address factors relative to cardiovascular health.

This annual ACT course provides basic training in general toxicology. Using pharmaceutical development as examples, participants will obtain an overall understanding of the principles of toxicology and nonclinical safety evaluation. The course will include discussion of regulatory case studies and hands-on analyses of nonclinical data. The course is intended to benefit individuals working with small and large molecules from biotechnology and pharmaceutical companies, CROs, and regulatory agencies, or individuals interested in or currently practicing toxicology. For the full course agenda and online registration, please visit the ACT website: https://www.actox.org/meetCourses/tprs2019.asp

General Highlights
Understanding and Fixing the Opioid Epidemic
Practice Management Portfolio (PMP) and Certificate of Attendance
Point of Care Ultrasound (PoCUS)
Workshops on New and Advanced Blocks such as PECs and serratus plane blocks,erector spinae, iPACK blocks, transverse oblique lumbar plexus and quadratum lumbarum blocks, and adductor canal blocks.
Innovative topics on social media and the modern learner, interdisciplinary sessions with surgeons, engaging experiences learning from a patient’s point of view, and expert QandA sessions on success in research
Multidisciplinary Experiences in Pediatric Regional, Obstetric Regional, Ambulatory Surgery, and Chronic Pain

Join the International Pediatric Dermatology Congress and gain insights on recent updates as well as be one of the contributors in the advancement of this field.
Prices: USD 199 to 2199

Global Summit on Toxicology and Pharmacology is designed to bring forth the most up to date information with a complete approach to diverse areas of interest. The topics of the summit will reflect the current advances, current trends, future trends and novel approaches in Toxicology and Pharmacology

Please join us with your peers from around the world for this wonderful opportunity to reach the largest assembly of participants from the Toxicology and Pharmacology community, meet with thought leadership experts, share your new research, and show off your cutting-edge expertise at this event.

ABSTRACT SUBMISSION: https://www.ologymavens.com/cme/pharmacology/toxicology-conferences/abstract-submission

REGISTRATION: https://www.ologymavens.com/cme/pharmacology/toxicology-conferences/registration

E: toxicologycongress@ologymavensmeetings.com

University Club, University of Pittsburgh
Pittsburgh, PA
May 1-2, 2019

For more details, please visit the AESOT website below.

Incorporating insights from 25+ industry leading speakers, this uniquely specific forum assesses key clinical and translational hurdles and the hottest emerging research necessary to achieve the potential of next-generation CKD drugs.

Website: https://diabetesmeet.conferenceseries.com/

Brochure: https://diabetesmeet.conferenceseries.com/conference-brochure.php

Email: diabetesmeet@diabetesconferences.net

This Conference provides a great opportunity for specialists with interest in intracranial hemorrhage and head injury management.

Abstract Submission Deadline: February 11 2019
Early Bird Registration Deadline: February 28 2019

Please join us at the 20th Pollutant Responses in Marine Organisms (PRIMO 20) meeting, to be held in Charleston SC from May 19 - May 22, 2019.

PRIMO 20 aims to provide an interdisciplinary scientific forum for discussing research on the environmental effects of anthropogenic activities on the health of our oceans and the organisms within. Scientific sessions will focus on the mechanisms of toxicity towards aquatic organisms, with sessions being held on –omic approaches, xenobiotic metabolizing enzymes, signal transduction, pharmaceutical and personal care products, nanoparticles and microplastics, developmental and transgenerational effects, and epigenetics, amongst others.

Abstract submission deadline - February 1, 2019

Student travel award deadline - February 1, 2019

Early bird registration - March 1, 2019

NEW DATE! On June 3-4, 2019, the National Academies of Sciences, Engineering, and Medicine will hold a workshop on “Evidence Integration in Chemical Assessments: Challenges Faced in Developing and Communicating Human Health Effect Conclusions” in Washington, DC. The workshop’s aim is to explore ways to overcome challenges that present themselves to the US Environmental Protection Agency (US EPA) during evidence integration in chemical assessments, with particular emphasis on the use of mechanistic data.

The event will explore many facets of evidence integration, which is a summary step of the systematic review in human health assessments conducted by the US EPA National Center for Environmental Assessment. Topics to be covered include (1) lessons learned from the evidence integration colloquium held in Lisbon, Portugal, in 2017; (2) best practices in evidence integration; (3) approaches for using mechanistic data to integrate evidence from animal and human studies; (4) case studies of systematic review-enabled evidence integration; and (5) practical approaches to expedited evidence integration.

The workshop organizing committee will review poster abstracts centered on at least one of the aforementioned topics, with an emphasis on the use of mechanistic data, for inclusion in poster presentations featured during the workshop. Interested parties should submit their abstracts for review by March 22, 2019, after which date the organizing committee will review them and select those to be included in the workshop.

To register and for additional details, please visit the

The course is intended to benefit individuals from biotechnology and pharmaceutical companies working with either small or large molecules, along with those from CROs, regulatory agencies and academia who are interested in toxicology and its application in safety assessment of drugs and medical products and for toxicologists early in their career seeking more in-depth knowledge and understanding of the role of toxicology in safety assessment. It is also suitable for scientists trained in ancillary disciplines (such as chemistry, biochemistry, molecular biology, medicine, etc.) making a career change to work in drug safety assessment.

Applications for CPD credits will again be made to EUROTOX and the Royal Society of Biology.

Register Today: https://execbs.eventsair.com/patdd-2019/patdd2019/Site/Register

Structural Biology 2019 aims to bring together leading academic scientists, researchers, research scholars and entrepreneurs to exchange and share their experiences and research results on all aspects of Structural Molecular Biology and Cell Biology. Structural Biology 2019 delivers a premier interdisciplinary platform for scientists, researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns as well as practical challenges encountered, and solutions adopted in the fields of Structural and Molecular Biology.

We invite all attendees to contribute throughout the sessions to make the event a memorable from the point of view of learning and Networking.

Structural Biology 2019

Lexis invites all the participants from around the world to attend Pain Medicine 2019 conference to be held in Toronto, Canada on August 30-31, 2019 at 9:00 am.
Our committees have worked to ensure a varied program for Pain Specialists, Anaesthesiologists, Chiropractors, Pharmacists, Acupuncture Doctors, Physiotherapists, Neuropsychologists, Cancer Specialists, Orthopaedicians, Professors/Associate Professors/Assistant Professors/Students in Pain Management, Deans / Vice Presidents of Pain Management Department, Directors / Managers & Business Intelligence Experts of Pharma Industries, Post Doctorals and Researchers in Pain Management, Pharmacology Department. And for any other information regarding the conference, kindly review the descriptions on the website. It includes all the details on the sessions that are planned for these 2 days. The purpose of this meeting is to deliver a comprehensive overview of the latest information, insights and practices in Pain Medicine.

When and Where?
Date: Friday, August 30-31, 2019
Time: 9:00 am – 06:00 pm
Location: Toronto, Canada

On behalf of the Safety Pharmacology Society (SPS) Board of Directors and Officers, we would like to invite you to attend the 2019 SPS Annual Meeting at the Centre de Convencions Internacional de Barcelona in the beautiful, art-inspired city of Barcelona, Spain.

Over the last few months, the 2019 Program and CE Committees have been hard at work organizing scientific programs and courses that include topics of interest to SPS Members and colleagues. The 2019 Scientific Program features a diverse range of scientific sessions organized into two concurrent themed tracks covering issues such as Cardiac Safety Concerns, New Models: In Vitro, Hot Topics in CNS, Immune Related Adverse Events, Thoughts on Translation, Personalized Medicine, Clinician Perspectives on Safety Pharmacology, Artificial Intelligence/In Silico, Biomarkers – The Far Reaching Value, Early Derisking Strategy and Techniques, Strategies for Getting to FIH and Beyond – Efficiently and Safely, Revisiting S7A and S7B and much more! This will ensure attendees can stay abreast of new content and developments in key areas of interest.

The meeting also offers a broad Continuing Education program both on an introductory level as well as advanced courses for the expert. A program outline is now available on the 2019 Meeting website. For those interested in increasing their knowledge, recognition and expertise in the field, we will also be holding the 2019 certification exam for the Diplomate in Safety Pharmacology on September 22 and invite all interested SPS members to consider sitting the exam this year.

In an effort to support attendance from our younger colleagues, please note that there are opportunities for Student and Jr. Investigator Travel and poster awards. We encourage you to submit an abstract for presentation as a poster to be featured in our Exhibit Hall. From these submissions a variety will be selected for short oral communications. The deadline to submit an abstract for presentation is June 15, 2019.

We also would like to highlight our Exhibit Hall, which will feature over 50 vendors offering direct access to CROs, as well as a variety of service and technology providers exhibiting the latest technology and developments relevant to the field.

We cordially invite you to become a member of our Society, become involved in our ongoing scientific activities and join us in Barcelona, Spain for our 2019 Annual Meeting this Fall!

The 40th Annual Meeting will be at the JW Marriott Desert Ridge in Phoenix, Arizona in 2019.

The Annual Meeting is the heart and soul of the College, a venue for discussing emerging trends in the field of toxicology, networking with friends and colleagues, and professional development. The program is designed by and for members with the goal of providing excellent quality scientific and regulatory content that is directly applicable to the practice of toxicology. The American College of Toxicology is a professional society of a size and culture ideal for scientists of all career stages seeking continuing education, novel and new ideas and strategies, and personal interactions with speakers, other members and guests, and exhibitors.

The 40th Annual Meeting will include a wide-ranging scientific program, a 40th Annual Meeting opening presentation followed by a welcome reception and dinner, the popular traditional poster session reception, awards ceremony and luncheon, distinguished plenary speakers, and networking events. The ACT Annual Meeting offers a unique opportunity for toxicologists preparing for the challenges and decisions that will affect public health and safety in years to come.